CD73-INHIBITOREN

European patent · EP4051688 · In force

Register entry

Publication number: EP4051688
Application number: EP20883288
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Oct 29, 2020
Published: Sep 7, 2022
Granted: Apr 23, 2025
Protection ends at the latest: Oct 28, 2040
Next annual fee due: Oct 31, 2026
IPC classes: C07H 19/20 (2006.01)
A61K 31/7064 (2006.01)
A61P 35/00 (2006.01)
A61P 31/12 (2006.01)
A61P 33/10 (2006.01)
A61P 25/28 (2006.01)
Priority: US 201962928138 P 30.10.2019
US 202062987806 P 10.03.2020
US 202063088646 P 07.10.2020
PCT application: PCT/US2020/057996 29.10.2020
PCT publication: WO2021/087136 06.05.2021
Filing language: English
Source: Swissreg

What the Federal Institute of Intellectual Property published about this title, newest first.

Mar 4, 2026
Change
Published in Swissreg on 04.03.2026
Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
Jun 18, 2025
Agent entered
Representative
MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 18.06.2025
Apr 23, 2025
Granted
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 23.04.2025

240 E. Grand Avenue 2nd Floor, South San Francisco, California 94080, US

122, rue de Genève, CP 61, 1226 Thônex